Detailed price information for Definitive Healthcare Corp Cl A (DH-Q) from The Globe and Mail including charting and trades.
Advancing FDA interactions on AMT-130 for Huntington’s disease; Type B meeting scheduled for the second quarter of 2026 ~ ~ Progressing AMT-130 toward expected UK regulatory submission; MAA on track ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results